サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1666158

マイクロ波焼灼装置の世界市場：2025年～2033年

Global Microwave Ablation Devices Market - 2025-2033

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
マイクロ波焼灼装置の世界市場：2025年～2033年
出版日: 2025年02月24日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マイクロ波焼灼装置の市場規模は、低侵襲治療を必要とするがんと他の慢性疾患の有病率の上昇によって拡大が牽引されます。肝臓、肺、腎臓腫瘍の世界の負担で、マイクロ波アブレーションは、伝統的な外科的方法と比較して、より速い処置時間、より高い組織破壊効率、合併症の減少を提供します。病院や外来手術センターでの画像誘導焼灼技術の採用も市場成長を促進しています。

例えば、米国がん協会の予測によると、2024年に米国では200万1,140人の新規がん患者が発生し、61万1,720人が死亡しています。

マイクロ波焼灼装置市場は、FDAとEMAからの厳しい規制承認とコンプライアンス要件のために重要な課題に直面しています。これらのガイドラインは、市場に出る前に機器の安全性と有効性を保証します。承認プロセスは時間がかかり、大規模な臨床試験、文書化、品質管理対策が必要です。このため、製品の上市が遅れたり、コストが増大したり、複雑化したりして、市場の成長が制限される可能性があります。

当レポートでは、世界のマイクロ波焼灼装置市場について調査し、市場の概要とともに、コンポーネントタイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第5章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第6章 コンポーネントタイプ別

  • 発電機
  • 配電システム
  • アクセサリ

第7章 用途別

  • 腫瘍科
  • 循環器科
  • 泌尿器科
  • 整形外科
  • その他

第8章 エンドユーザー別

  • 病院
  • 外来手術センター
  • クリニック

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢

第11章 企業プロファイル

  • AngioDynamics
  • Medtronic Plc
  • Boston Scientific Corporation
  • Johnson &Johnson Inc
  • Emblation
  • MedWaves, Inc
  • Symple Surgical
  • Urologix, LLC
  • Varian Medical Systems Inc
  • Huber Suhner
  • Similar data will be provided for each market player.
  • Miramar Labs, Inc
  • Symple Surgical

第12章 付録

目次
Product Code: MD9150

The Global Microwave Ablation Devices Market reached US$ 378.16 million in 2024 and is expected to reach US$ 1145.74 million by 2033, growing at a CAGR of 13.0% during the forecast period 2025-2033.

Microwave ablation devices are medical instruments that use microwave energy to destroy abnormal tissues, such as tumors or unwanted growths. They emit high-frequency electromagnetic waves, causing water molecules in tissues to vibrate and produce heat, leading to coagulative necrosis. They are widely used in oncology for treating liver, lung, kidney, bone tumors, cardiovascular, urological, and gynecological procedures. Compared to other thermal ablation techniques, microwave ablation offers deeper tissue penetration, higher temperatures, and faster treatment times.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Cancer and Other Chronic Diseases

The microwave ablation devices market is driven by the rising prevalence of cancer and other chronic diseases requiring minimally invasive treatments. With the global burden of liver, lung, and kidney tumors, microwave ablation offers faster procedure times, higher tissue destruction efficiency, and reduced complications compared to traditional surgical methods. The adoption of image-guided ablation techniques in hospitals and ambulatory surgical centers is also driving market growth.

For instance, according to American Cancer Society predicts in 2024, the US experienced 2,001,140 new cancer cases and 611,720 deaths, based on data from central cancer registries and the National Center for Health Statistics.

Stringent Regulatory Approvals

The microwave ablation devices market faces significant challenges due to stringent regulatory approvals and compliance requirements from the FDA and EMA. These guidelines ensure safety and efficacy of devices before they reach the market. The approval process is time-consuming and requires extensive clinical trials, documentation, and quality control measures. This can delay product launches, increase costs, and complexity, potentially limiting market growth.

Segment Analysis

The global Microwave Ablation Devices market is segmented based on Component Type, Application, End User and Region.

Component Type:

Generator segment is expected to dominate the Microwave Ablation Devices market share

The generator segment holds a major portion of the microwave ablation devices market share and is expected to continue to hold a significant portion of the microwave ablation devices market share during the forecast period.

Microwave ablation devices rely on generators for energy generation, controlling the frequency, power output, and duration of microwave emissions. Advancements in generator technology, including improved energy efficiency, real-time monitoring, and integration with imaging systems, enhance the accuracy and safety of ablation procedures. The growing demand for generators with higher power output and better thermal control drives market innovations, contributing to the expansion of microwave ablation therapies.

End User:-

Hospitals segment is the fastest-growing segment in Microwave Ablation Devices market share

The hospitals segment is the fastest-growing segment in the Microwave Ablation Devices market share and is expected to hold the market share over the forecast period.

Hospitals are leading the market in microwave ablation devices due to their primary role in healthcare. With increasing cases of cancer and chronic diseases requiring ablation therapy, hospitals invest in advanced systems for minimally invasive treatment. Specialized oncology and radiology departments enable the integration of microwave ablation with imaging technologies like CT and ultrasound. Government funding, reimbursement policies, and skilled healthcare professionals support the widespread use of microwave ablation devices in clinical practice.

For instance, in January 2025, Sringeri Sharada Equitas (SSE) hospital in Chennai has introduced Microwave Ablation treatment for affordable cancer treatment and curing, using microwave energy to kill and shrink tumor cells in organs like kidney, lungs, and liver.

Geographical Analysis

North America is expected to hold a significant position in the Microwave Ablation Devices market share

North America holds a substantial position in the Microwave Ablation Devices market and is expected to hold most of the market share due to advanced healthcare infrastructure, minimally invasive procedures, and investment in medical technology innovation. Key players like Medtronic and Boston Scientific develop cutting-edge ablation technologies. The rising prevalence of cancer, particularly liver and lung cancer, and government initiatives for treatment also increase demand for microwave ablation procedures. Favorable reimbursement policies and skilled healthcare professionals further contribute to market expansion.

For instance, in July 2024, Siemens Healthineers' Varian has received FDA clearance for its IntelliBlate microwave ablation system, designed for soft tissue ablation. The system offers clinicians greater predictability, precision, and control, forming the foundation of a future-focused, integrated microwave ablation ecosystem.

Europe is growing at the fastest pace in the Microwave Ablation Devices market

Europe holds the fastest pace in the Microwave Ablation Devices market and is expected to hold most of the market share is driven by rising healthcare expenditure, increased awareness of minimally invasive cancer treatments, and advancements in imaging technology. Countries like Germany, France, and the UK are leading due to strong research and development, rising cancer cases, well-regulated healthcare policies, and funding for cancer treatment programs. The expansion of ambulatory surgical centers and preference for outpatient procedures also contribute to market growth.

For instance, in March 2024, Creo Medical Group has made significant progress in the field of minimally invasive surgical endoscopy for pre-cancer and cancer patients. Professor Pallav Shah and Dr Christopher Orton at the Royal Brompton Hospital have become the first specialists to perform a robotic guided microwave ablation of lung tissue in the same sitting as a diagnostic procedure. The procedure, which took three minutes, involved the ablation of a 27mm cancerous nodule in a patient's lung.

Competitive Landscape

The major global players in the Microwave Ablation Devices market include AngioDynamics, Medtronic Plc, Boston Scientific Corporation, Johnson & Johnson Inc, Emblation, MedWaves, Inc, Symple Surgical, Urologix, LLC, Varian Medical Systems Inc, Huber Suhner and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Microwave Ablation Devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Component Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Cancer and Other Chronic Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulatory Approvals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 6.1.2. Market Attractiveness Index, By Component Type
  • 6.2. Generator*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Power Distribution System
  • 6.4. Accessories

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Oncology*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiovascular
  • 7.4. Urology
  • 7.5. Orthopedic
  • 7.6. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Clinics

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. AngioDynamics*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic Plc
  • 11.3. Boston Scientific Corporation
  • 11.4. Johnson & Johnson Inc
  • 11.5. Emblation
  • 11.6. MedWaves, Inc
  • 11.7. Symple Surgical
  • 11.8. Urologix, LLC
  • 11.9. Varian Medical Systems Inc
  • 11.10. Huber Suhner
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. Miramar Labs, Inc*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Symple Surgical
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us